The relationships between insulin resistance and components of metabolic syndrome in Taiwanese Asians

International Journal of Clinical Practice

Volumn 59, Issue 12, 2005, Pages 1408-1416

  Pei, D ^a   Kuo, S W ^a   Wu, D A ^a   Lin, T Y ^b   Hseih, M C ^a   Lee, C H ^c   Hsu, W L ^b   Chen, S P ^d   Sheu, W H H ^e   Li, Jer Chuan ^a,f  

^a TZU CHI UNIVERSITY   (Taiwan)

^b BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^c TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^d Armed Forces Sung Shan Hospital   (Taiwan)

^e TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^f NONE   (Taiwan)

Author keywords

Insulin resistance; Insulin suppression test; Metabolic syndrome; NCEP ATP III; WHO

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; AGED; ARTICLE; ASIAN; BLOOD SAMPLING; BODY MASS; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; POPULATION DISTRIBUTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SCHOOL CHILD; SEX DIFFERENCE; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; STEADY STATE; TAIWAN; WORLD HEALTH ORGANIZATION; BLOOD; BLOOD PRESSURE; CHILD; COHORT ANALYSIS; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; MIDDLE AGED;

ADOLESCENT; ADULT; AGED; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; CHILD; CHOLESTEROL, HDL; COHORT STUDIES; CORONARY DISEASE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; FEMALE; HUMANS; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; TAIWAN; TRIGLYCERIDES;

EID: 33646829096     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1368-5031.2005.00661.x     Document Type: Article

References (40)

1. Vague J. The degree of masculine differentiation of obesity: A factor determining predisposition to diabetes, arteriosclerosis, gout and uric calculus disease. Am J Clin Nutr 1956; 4: 20-34.
2. Avogaro P, Crepaldi G, Enzi G et al. Associazione di iperlipidemia, diabete mellito e obesitàdi medio grado. Acta Diabetol Lat 1967; 4: 36-41.
3. Haller H. Epidemiologie und assoziierte risikofaktoren der hyperlipoproteinamie. Z Gesamte Inn Med 1977; 32: 124-8.
4. Singer P. Zur diagnostik der primaren hyperlipoproteinamien. Z Gesamte Inn Med 1977; 32: 129-33.
5. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-607.
6. Ferrannini E, Haffner SM, Mitchell BD et al. Hyperinsulinaemia: The key feature of a cardiovascular and metabolic syndrome. Diabetologia 1991; 34: 416-22.
7. Alberti KGMM, Zimmet PZ. Definition, diagnosis, and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diabet Med 1998; 15: 539-53.
8. WHO. Definition, Diagnosis and Classification of Diabetes: Mellitus and its Complications. Part 1: Diagnosis and Classification of Diabetes Mellitus 1999. Geneva: World Health Organization. Available at http://www.whqlibdoc.who.int/hq/1999/WHO_NCD_NCS_99.2.pdf. Accessed February 12, 2005.
9. Balkau B, Charles MA. Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet Med 1999; 16: 442-3.
10. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-97.
11. International Diabetes Federation. The IDF Consensus Worldwide Definition of the Metabolic Syndrome 2005. Available at http://www.idf.org/webdata/docs/Metabolic_syndrome_definition.pdf. Accessed May 2, 2005.
12. Alexander C, Landsman P, Teutsch S et al. NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes 2003; 52: 1210-4.
13. Lakka H-M, Laaksonen D, Lakka T et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002; 288: 2709-16.
14. Laaksonen D, Lakka H-M, Niskanen L et al. Metabolic syndrome and development of diabetes mellitus: Application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study. Am J Epidemiol 2002; 156: 1070-7.
15. Modan M, Halkin H, Almog S et al. Hyperinsulinaemia: A link between hypertension, obesity and glucose intolerance. J Clin Invest 1985; 75: 809-17.
16. Shen SW, Reaven GM, Farguhar JW. Comparison of impedance to insulin-mediated glucose uptake in normal subjects and in subjects with latent diabetes. J Clin Invest 1970; 49: 2151-60.
17. Matthews DR, Hosker JP, Rudenski AS et al. Homeostasis model assessment: insulin resistance and b-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-9.
18. Emoto M, Nishizawa Y, Maekawa K et al. Homeostasis model assessment as a clinical index of insulin resistance in type 2 diabetic patients treated with sulfonylureas. Diabetes Care 1999; 22: 818-22.
19. Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: Comparison with the euglycemic insulin clamp. Diabetes Care 1999; 22: 1462-70.
20. Herbert V, Lauk S, Gottlieb C. Coated charcoal immunoassay of insulin. J Clin Endocrinol Metab 1965; 25: 1375-84.
21. Hallenbeck C, Reaven GM. Variations in insulin-stimulated glucose uptake in healthy individuals with normal glucose tolerance. J Clin Endocrinol Metab 1987; 64: 1169-73.
22. Haffner SM, Stern MP, Hazuda HP et al. Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes? JAMA 1990; 263: 2893-8.
23. McPhillips JB, Barrett-Connor E, Wingard DL. Cardiovascular disease risk factors prior to the diagnosis of impaired glucose tolerance and non-insulin-dependent diabetes mellitus in a community of older adults. Am J Epidemiol 1990; 131: 443-53.
24. Zimmet P, Alberti KGMM. The changing face of macrovascular disease in non-insulin-dependent diabetes mellitus: An epidemic in progress. Lancet 1997; 350 (Suppl. 1): S1-4.
25. Mykkänen L, Kuusisto J, PyöräläK et al. Cardiovascular disease risk factors as predictors of type 2 (non-insulin-dependent) diabetes mellitus in early subjects. Diabetologia 1993; 36: 553-9.
26. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: A method for quantifying insulin secretion and resistance. Am J Physiol 1979; 237: E214-23.
27. Katz A, Nambi SS, Mather K et al. Quantitative insulin sensitivity check index: A simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000; 85: 2402-10.
28. Bonora E, Targher G, Alberiche M et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity. Diabetes Care 2000; 23: 57-63.
29. Abbasi F, Reaven GM. Evaluation of the quantitative insulin sensitivity check index as an estimate of insulin sensitivity in humans. Metabolism 2002; 51: 235-7.
30. Greenfield MS, Doberne L, Kraemer F et al. Assessment of insulin resistance with insulin suppression test and the euglycemic clamp. Diabetes 1981; 30: 387-92.
31. Reaven GM. Insulin resistance, hypertension, and coronary heart disease. J Clin Hypertens 2003; 5: 269-74.
32. Lender D, Arauz-Pacheco C, Adams-Huet B et al. Essential hypertension is associated with decreased insulin clearance and insulin resistance. Hypertension 1997; 29 (Pt 1): 111-4.
33. Mgonda YM, Ramaiya KL, Swai ABM et al. Insulin resistance and hypertension in non-obese Africans in Tanzania. Hypertension 1998; 31: 114-8.
34. Goff DC Jr, Zaccaro DJ, Haffner SM et al., Insulin Resistance Atherosclerosis Study. Insulin sensitivity and the risk of incident hypertension: Insights from the Insulin Resistance Atherosclerosis Study. Diabetes Care 2003; 26: 805-9.
35. Lewington S, Clarke R, Qizilbash N et al. Age-specific relevance of usual blood pressure to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies. Prospective Studies Collaboration. Lancet 2002; 360: 1903-13.
36. Chobanian AV, Bakris GL, Black HR et al. Seventh report of the joint National Committee Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42: 1206-52.
37. Lin WY, Lee LT, Chen Y et al. Optimal cut-off values for obesity: Using simple anthropometric indices to predict cardiovascular risk factors in Taiwan. Int J Obes Relat Metab Disord 2002; 26: 1232-8.
38. Mykkanen L, Zaccaro DJ, Wagenknecht LE et al. Microalbuminuria is associated with insulin resistance in nondiabetic subjects: The insulin resistance atherosclerosis study. Diabetes 1998; 47: 793-800.
39. Hodge AM, Dowse GK, Zimmet PZ. Microalbuminuria, cardiovascular risk factors, and insulin resistance in two populations with a high risk of type 2 diabetes mellitus. Diabet Med 1996; 13: 441-9.
40. Zavaroni I, Bonini L, Gasparini P et al. Dissociation between urinary albumin excretion and variables associated with insulin resistance in a healthy population. J Intern Med 1996; 240: 151 -6.